Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B vaccine adherence among transgender women
ISRCTN60659382Phase 4Completed
- Sponsor
- FAPEG
- Start
- Apr 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by FAPEG. Primary endpoint: Adherence to at least three vaccine doses. Started Apr 2018; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ISRCTN60659382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN60659382.